RAPIDSCREEN RS-2000
Overview
The RAPIDSCREEN RS-2000 was a Computer-Aided Detection (CAD) system developed by Deus Technologies and later marketed by Riverain Medical Group (now Riverain Technologies). It was designed to assist physicians in the detection of solitary pulmonary nodules on digitized frontal chest radiographs. The system identified features associated with nodules ranging from 9 to 30 mm in size, which could represent early-stage lung cancer. It was intended for use as an aid only after a physician had performed an initial interpretation of the radiograph. The device received its initial FDA Premarket Approval (PMA) in July 2001. The RS-2000 was later supplemented by the RS-2000D, a network-based version, and eventually evolved into Riverain Technologies’ current suite of ClearRead AI solutions for cardiothoracic imaging. The RAPIDSCREEN RS-2000 product was discontinued in September 2006, though support for existing units continued. It is important to note that this tool is a medical imaging analysis system and not a physician directory tool.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Computer-Aided Detection (CAD)
- Identification of solitary pulmonary nodules (9-30 mm)
- Analysis of digitized frontal chest radiographs
- Aid in early-stage lung cancer detection
- Uses fuzzy logic, neural networks, and advanced image processing (for the broader RapidScreen line)
Use Cases
- Assisting radiologists in interpreting chest radiographs
- Improving detection efficiency of lung nodules
- Screening for early-stage lung cancer
- Enhancing diagnostic confidence in chest imaging
What Physicians Need to Know
When using RAPIDSCREEN RS-2000, remember it is an aid and should be used *after* your initial interpretation of the radiograph. The system is optimized for solitary pulmonary nodules 9-30 mm in size on digital radiography chest studies. Be aware that while the system can significantly improve nodule detection, especially for smaller cancers, it may still produce false positives, though these have been reduced over time. Leverage the vessel and bone suppression technology to enhance visualization of subtle pathology. The integration with platforms like RapidAI can streamline workflows and provide a unified environment for various AI tools.
RAPIDSCREEN RS-2000 (and the broader ClearRead suite) offers extensive integration capabilities. It can connect directly with PACS workstations and is available through major AI platforms and orchestrators, including the Rapid Enterprise™ Platform. Riverain Technologies also partners with modality manufacturers and RIS companies, offering both on-premise and cloud deployment options. This broad compatibility aims to minimize disruption and allow health systems to scale AI within their existing infrastructure.
Details
| Category | Oncology AI, Radiology & Imaging AI |
| Pricing | Unknown |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Oncology, Pulmonology, Radiology |
What the Web Says
The RAPIDSCREEN RS-2000 is a computer-aided detection (CAD) system developed by Deus Technologies and later acquired by Riverain Technologies. It is designed to digitize and analyze chest x-rays to identify regions of interest that may indicate early-stage lung cancer, assisting radiologists in their review. The system has received premarket approval from the FDA.
Overall: MixedStrengths
- Aids radiologists in detecting pulmonary nodules during chest x-ray review.
- Can help physicians identify early-stage lung cancer.
- Utilizes image processing software with image enhancement and pattern recognition techniques.
- Can be used with both analog (film-based) and digital radiography systems.
- Clinical studies suggest it can help radiologists find more cancers in the 9-14 mm size range.
- Can integrate with commercially available PACS software.
Limitations
- Some studies indicated a notable number of false-positive marks per image.
- The information available is largely from the early to mid-2000s, suggesting the technology might be older or have been succeeded by newer versions like ClearRead CT.
- No recent reviews from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra specifically for the RS-2000 were found, indicating a lack of current public opinion.
- Other products with similar names (e.g., car radar detectors, emissions testing) frequently appear in search results, making specific information about the medical device harder to isolate.
Based on reviews from: fda.gov, scispace.com, axisimagingnews.com, paperdue.com, auntminnie.com, aidoc.com, ajronline.org, federalregister.gov
Last updated: 2026-10-31
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate RAPIDSCREEN RS-2000
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for RAPIDSCREEN RS-2000.
No videos found. Search YouTube directly
